GlassScriptPhysician profile
Ryan Diederich
NPI 1942422498
$3,124.93
in general payments reported to CMS, 2019-2025
9 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $319 · 2021: $368 · 2022: $832 · 2023: $440 · 2024: $217 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,114.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $1,201.18 | 2019-2025 | |
| Abbvie INC. | $673.86 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $636.75 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $242.65 | 2019-2021 | |
| Davol INC. | $164.03 | 2022 | |
| Mentor Worldwide LLC | $118.31 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Sientra, INC. | $39.86 | 2021 | |
| Motiva USA, LLC | $38.20 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $10.09 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Diederich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.